Cambridge Innovation Capital

Paris, France
cb
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. Since our inception in 2013, we have raised £275million to invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics.
Founded:2013
Firm Location:Paris, France • London • Cambridge, United Kingdom
Investor Firms That Co-Invest with Cambridge Innovation Capital
Flagship VenturesLazerow VenturesHealthCapBeringeaOctopus VenturesToba CapitalFelix Capital.406 VenturesARCH Venture PartnersFJ LabsInsight PartnersSofinnova InvestmentsParkwalk AdvisorsForbionTotalEnergies VenturesAtlantic Bridge
Cambridge Innovation Capital Team
Photo of Michael Anstey, Partner at Cambridge Innovation Capital
Michael Anstey
Sweet spot: $3.3M
Range: $600K - $6.0M
Investors in Cambridge (United Kingdom)
Investors in AI, Investors in AI, Investors in BioTech, Investors in BioTech, Investors in DeepTech, Investors in DeepTech, Investors in FinTech, Investors in FinTech
to see your intro paths to Michael
Photo of Anne Horgan, Partner at Cambridge Innovation Capital
Anne Horgan
Sweet spot: $3.3M
Range: $600K - $6.0M
Investors in Cambridge (United Kingdom)
Investors in AI, Investors in AI, Investors in BioTech, Investors in BioTech, Investors in DeepTech, Investors in DeepTech, Investors in FinTech, Investors in FinTech
to see your intro paths to Anne
Photo of Edward Inns, Associate at Cambridge Innovation Capital
Edward Inns
Sweet spot: $3.3M
Range: $600K - $6.0M
Investors in Cambridge (United Kingdom)
Investors in AI, Investors in AI, Investors in BioTech, Investors in BioTech, Investors in DeepTech, Investors in DeepTech, Investors in FinTech, Investors in FinTech
to see your intro paths to Edward
Photo of Ian Lane, Partner at Cambridge Innovation Capital
Ian Lane
Sweet spot: $3.3M
Range: $600K - $6.0M
Investors in Cambridge (United Kingdom)
Investors in AI, Investors in AI, Investors in BioTech, Investors in BioTech, Investors in DeepTech, Investors in DeepTech, Investors in FinTech, Investors in FinTech
to see your intro paths to Ian
Photo of Rob Sprawson, Partner at Cambridge Innovation Capital
Rob Sprawson
Sweet spot: $3.3M
Range: $600K - $6.0M
Investors in Cambridge (United Kingdom)
Investors in AI, Investors in AI, Investors in BioTech, Investors in BioTech, Investors in Diagnostics, Investors in Diagnostics, Investors in Digital Health, Investors in Digital Health, Investors in FinTech, Investors in FinTech, Investors in IoT, Investors in IoT, Investors in Pharmaceuticals, Investors in Pharmaceuticals
to see your intro paths to Rob
Photo of Robert Tansley, Partner at Cambridge Innovation Capital
Robert Tansley
Sweet spot: $3.3M
Range: $600K - $6.0M
Investors in Cambridge (United Kingdom)
Investors in AI, Investors in AI, Investors in BioTech, Investors in BioTech, Investors in DeepTech, Investors in DeepTech, Investors in FinTech, Investors in FinTech
to see your intro paths to Robert
Photo of Christopher Tapper, Senior Associate at Cambridge Innovation Capital
Christopher Tapper
Sweet spot: $3.3M
Range: $600K - $6.0M
Investors in Cambridge (MA)
Investors in AI, Investors in AI, Investors in BioTech, Investors in BioTech, Investors in DeepTech, Investors in DeepTech, Investors in FinTech, Investors in FinTech, Investors in London (Other Lists)
to see your intro paths to Christopher
Photo of Andrew Williamson, Managing Partner at Cambridge Innovation Capital
Andrew Williamson
Sweet spot: $3.3M
Range: $600K - $6.0M
Investors in Cambridge (United Kingdom)
Investors in AI, Investors in AI, Investors in BioTech, Investors in BioTech, Investors in DeepTech, Investors in DeepTech, Investors in FinTech, Investors in FinTech, Investors in Material Science, Investors in Material Science
to see your intro paths to Andrew